ACE2 and COVID-19: In comparing COVID-19 patients with the control group, the increase in the serum level of CRP in the ACE2 TT genotype was significant compared to CC + CT genotypes (12.05 ± 11.39 vs 3.14 ± 1.69; p = 0.029).